pandemic
R&D/ Views & Analysis/ Views and analysis
Preventing the next pandemic: Supporting early-stage R&D
Ben Hargreaves
AstraZenca, COVID-19, GSK, pandemic, preventing the next pandemic
0 Comment
Market Access/ Views & Analysis/ Views and analysis
Pharma’s post-pandemic launch performance problem: what’s the prognosis?
mike.hammerton@pharmaphorum.com
COVID-19, IQVIA, launch excellence, pandemic, Sarah Rickwood
0 Comment
R&D/ Views & Analysis/ Views and analysis
Preventing the next pandemic: Learning the lessons
Ben Hargreaves
covid, covid19, pandemic, pharma, preventing the next pandemic, WHO
0 Comment
Patients/ Views & Analysis/ Views and analysis
From healthcare to human care: Shaping a healthier society
mike.hammerton@pharmaphorum.com
COVID-19, mental health, pandemic, patients
0 Comment
Deep Dive/ Oncology/ Views & Analysis/ Views and analysis
Surprise pandemic lessons for pharma
mike.hammerton@pharmaphorum.com
Deep Dive, Deep Dive: Oncology, IQVIA, Oncology, pandemic, SARS
0 Comment
Deep Dive/ Oncology/ Views & Analysis/ Views and analysis
Oncology and a year of COVID: lessons for the future
mike.hammerton@pharmaphorum.com
covid, Deep Dive, Deep Dive: Oncology, Frances O’Connor, Lucid, Lucid Group, Oncology, pandemic
0 Comment
Deep Dive/ Market Access/ Views & Analysis/ Views and analysis
A year on: pandemic driven trends in HCP engagement
mike.hammerton@pharmaphorum.com
Deep Dive, Deep Dive: Market Access, HCP, IQVIA, market access, pandemic
0 Comment
Digital/ Views & Analysis/ Views and analysis
Could a smartphone cough app stop future pandemics?
Richard Staines
COVID-19, digital, infectious diseases, influenza, pandemic, tuberculosis
0 Comment